INTRODUCTION
============

IgA is the major Ig isotype in mucosal secretions and constitutes the great majority of the Ig synthesized in mucosal tissues ([@B1],[@B2]). IgA class-switch recombination (CSR) mainly takes place in Peyer\'s patches (PP) and then, IgA^+^ B cells migrate through the lymph and blood circulation and eventually home to lamina propria of the intestine ([@B3]). TGF-β1 is known to induce IgA and IgG2b CSR in murine B cells ([@B4]-[@B9]). In addition, TGF-β1 inhibits B cell proliferation and cell cycle progression in the mid to late G1 phase of the cell cycle ([@B10]-[@B12]).

Activin A, a member of the TGF-β superfamily, is a local regulator of cell growth and differentiation ([@B13]). Activin A is known to be produced by Th2 but not by Th1 cells upon activation ([@B14]). We have recently shown that activin A stimulates IgA expression in mouse B cells ([@B15]). Thus, activin A increased the expression of Ig germ-line α transcripts, an indicative of IgA CSR, via Smad3 and Smad4 leading to increased IgA secretion.

Since both activin A and TGF-β1 use the same proteins (Smad3 and/or Smad4) in signal transduction and enhances IgA response, it was necessary to determine whether the activity of activin A is related to that of TGF-β1. We found that activin A little affected B cell proliferation, which was contrasted to anti-proliferative activity of TGF-β1. In addition, we found that activin A can independently modulate B cells to express IgA and that this may occur in mesenteric lymph nodes of the gut.

MATERIALS AND METHODS
=====================

Animals
-------

BALB/c mice were purchased from Orient. Co. Ltd. (Gyeonggi-do, Korea) and maintained in an animal environmental control chamber (Myung Jin Inst. Co., Seoul, Korea). Animals were fed Purina Laboratory Rodent Chow 5001 *ad libitum*. Eight to twelve weeks age of mice were used in this study. Animal care was in accordance of with the institutional guidelines set forth by Kangwon National University.

B cell preparations and cell culture
------------------------------------

The murine B lymphoma cell line, CH12F3-2A was provided by Dr. T. Honjo (Osaka University, Japan) ([@B16]). These cells were cultured at 37℃ in a humidified atmosphere containing 5% CO~2~ in RPMI 1,640 medium (Sigma) supplemented with 10% FBS, 50µM 2-ME, 5 mM HEPES, penicillin (100 U/ml)/streptomycin (100µg/ml). Mouse spleen B cell suspensions were prepared as described before ([@B4]) and whole mesenteric lymph node cells were prepared as teasing the tissues with forceps.

Isotype-specific ELISA
----------------------

ELISAs were performed as described previously ([@B17]). The reaction products were measured at 405 nm with an ELISA reader (Molecular Devices VERSAMAX reader, Molecular Devices, Sunnyvale, CA, USA).

CFSE staining and analysis
--------------------------

Isolated mouse spleen B cells were labeled with a CFSE kit (Invitrogen Life Technologies, Carlsbad, CA, USA), according to the manufacture\'s instruction, and added with LPS, activin A (10 ng/ml), and TGF-β1 (0.2 ng/ml). Dilution of CFSE was measured by counting 30,000 viable cells with a FACSCalibur (BD Biosciences).

RESULTS AND DISCUSSION
======================

Activin A do not alter the cell proliferation and viability
-----------------------------------------------------------

We have recently shown that activin A selectively stimulates IgA expression ([@B15]). However, the relationship between actions of activin A and TGF-β1 in the context of IgA CSR is unclear at the moment. In this regard, we have demonstrated in the earlier study that anti-proliferative activity of TGF-β facilitates IgA CSR leading to an increase of IgA production ([@B18]). Therein, we first examined the effect of activin A on the growth of murine spleen B cells. LPS is generally adopted for the non-specific stimulation of mouse B cells. As shown in [Fig. 1](#F1){ref-type="fig"}, LPS increased cell viability up to 4 day of culture. Effect of Activin A on the cell viability was marginal while TGF-β1 substantially inhibited it. Subsequently, we tested the effect of activin A on B cell proliferation. In parallel to cell viability, Activin A had no influence on cell proliferation though anti-proliferative activity of TGF-β1 was evident ([Fig. 2](#F2){ref-type="fig"}). These results suggest that activin A increases IgA expression through the mechanism different from that of TGF-β1 and that activin A has such activity without inhibiting cell proliferation.

Activin A specifically enhances IgA expression independent of the activity of TGF-β1
------------------------------------------------------------------------------------

Then, how does activin A stimulate B cells to express IgA isotype expression? To assess its underlying mechanism, we examined the possible involvement of TGF-β in the activin A-induced IgA secretion. In the culture of CH12F3-2A B cell lymphoma, the activin A-induced IgA production was abrogated by anti-activin A Ab in a dose dependent manner ([Fig. 3](#F3){ref-type="fig"}). In contrast, anti-TGFβ1 Ab failed to eliminate the IgA response enhanced by activin A. Moreover, in normal spleen B cell cultures, a similar pattern of IgA secretion was observed when anti-activin A Ab and anti-TGFβ1 Ab were treated as shown in [Fig. 4](#F4){ref-type="fig"}. On the other hand, anti-activin A Ab or anti-TGFβ1 Ab little affected secretion patterns of IgM, IgG2b, and IgG3. These results indicate that activin A selectively induces IgA expression and that this activity of activin A is independent of that of TGF-β1. Furthermore, these results exclude the possibility that activin A has such activity through induction of TGF-β1 production.

Effect of activin A on IgA secretion by mesenteric lymph node B cells
---------------------------------------------------------------------

Peyer\'s patch (PP) is the most important gut-associated lymphoid tissue, where most of IgA B cells are committed ([@B19]). Therein, it is difficult to isolate surface IgA negative B cells from PP. On the other hand, mesenteric lymph node (MLN) B cells are also known to be the site for IgA B cell commitment ([@B20],[@B21]). Here, we were interested if activin A affects IgA production by MLN B cells. As shown in [Fig. 5](#F5){ref-type="fig"}, activin A, as similar to TGF-β1, increased IgA secretion by MLN cells but neither IgG1 nor IgG2b.

In summary, we demonstrate in this study that activin A, as similar to TGF-β1, selectively increases IgA expression. Nevertheless, Activin A had no influence on cell proliferation, which is in contrast to the anti-proliferative property of TGF-β1. We have recently shown that activin A, like TGF-β1 adopts Smad3 and Smad4 as the main signaling mediators ([@B15]). Therefore, it still remains to determine the mechanism by which activin A causes IgA isotype switching, distinguishing from that of TGF-β1. Finally we observed that activin A can stimulate mesenteric lymph node B cells to produce IgA. These results raise the possibility that activin A may have important effects on the expression of IgA in the gut.
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![Effect of activin A and TGF-β1 on the growth kinetics of splenic B cells. Normal spleen B cells (1×10^6^) stimulated with LPS were cultured in the presence of TGF-β1 (0.2 ng/ml) and activin A (10 ng/ml). Numbers of viable cells were enumerated by trypan blue exclusion. Data are means±SEM (bars) of triplicate culture wells.](in-9-133-g001){#F1}

![Effect of activin A on B cell proliferation. CFSE-labeled splenic B cells (1×10^6^) were cultured as in [Fig. 1](#F1){ref-type="fig"}. After 48 h, 72 h, and 96 h incubation, B cell proliferation was assessed by analyzing the dilution of CFSE in the same number of viable cells.](in-9-133-g002){#F2}

![Effect of anti-activin A Ab on IgA secretion by B lymphoma cells. B lymphoma cells were stimulated with LPS (12.5µg/ml) and activin A (10 ng/ml). Titrated anti-activin A Ab and anti-TGF-β Ab were pre-incubated for 1 h at room temperature before addition to culture. Supernatants were harvested after 3 days of culture. IgA secretion was determined by ELISA. Data are means of triplicate cultures±SEM.](in-9-133-g003){#F3}

![Effect of anti-activin A Ab on Ig secretion by normal spleen B cells. Mouse spleen B cells were stimulated with LPS (12.5 g/ml) and activin A (10 ng/ml). As in [Fig. 3](#F3){ref-type="fig"}, anti-activin A Ab (0.5µg/ml) and anti-TGF-β Ab (5µg/ml) were added to cultures. Supernatants were harvested after 7 days of culture. Secretion of Ig isotypes was determined by ELISA. Data are means of triplicate cultures±SEM.](in-9-133-g004){#F4}

![Activin A increases IgA secretion by mesenteric lymph node cells. Mesenteric lymph node (1×10^6^) cells were treated 10 ng/ml of activin A, and 0.2 ng/ml of TGF-β1. Supernatants were harvested after 7 days of culture. IgA, IgG1, and IgG2b secretion was determined by ELISA. Data are means of triplicate cultures±SEM.](in-9-133-g005){#F5}
